| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.41 | 2e-08 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0008 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.23 | 0.001 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.007 |